MDR summary reports initially would supplement standard reports under "reengineering" concept.
This article was originally published in The Gray Sheet
MDR SUMMARY REPORTING WOULD SUPPLEMENT CURRENT REPORTING REQUIREMENTS in the short-term under a reengineering proposal being crafted by FDA's Center for Devices and Radiological Health. The proposal ultimately is intended to allow manufacturers to report many adverse events in summary form rather than individually. However, until current medical device reporting rules are revised, manufacturers would voluntarily submit summary reports in addition to individual event reports.
You may also be interested in...
The Environmental Working Group and Scientific Analytical Institute say inadequate testing of talc-containing personal-care products is to blame for findings of asbestos in cosmetics, including three of 21 powder-based cosmetics SAI analyzed at EWG’s request. They continue to push for updated testing standards that include electron microscopy as a core component.
Can Atlas Biomed unlock Japan's self-care market with its direct-to-consumer DNA and microbiome tests? HBW Insight catches up with the company's co-founder and CEO to discuss this and also how Atlas has been driving its European expansion plans despite coronavirus.
France's ANSES warns women using oral contraceptives not to use a supplement marketed by UK firm Hairburst after linking the product's consumption to two cases of severe acute hepatitis.